Posts

The invisible plant technology of the prehistoric Phili...

Stone tools bear microscopic evidence of ancient plant technology, according to ...

Study advances understanding of anthropogenic effects o...

RIVERSIDE, Calif. — Anthropogenic aerosols — aerosols originating from human act...

A new study published in NEJM Evidence with University ...

CLEVELAND – Data from a new study published in NEJM Evidence shows promise for p...

Displays controlled by flexible fins and liquid droplet...

CHAMPAIGN, Ill. — Flexible displays that can change color, convey information an...

Deep-learning chest radiograph model predicts mortality...

Leesburg, VA, June 30, 2023—According to an accepted manuscript published in ARR...

Age prediction from human blood plasma using proteomic ...

“[…] we see our work as an indication that combining different molecular data ty...

AI with volumetric thresholds facilitate opportunistic ...

Leesburg, VA, June 30, 2023—According to an accepted manuscript published in ARR...

Q&A: How can the US maintain access to essential drugs?

Carrie Harney, the vice president of government and regulatory Affairs at US Pha...

Genprex’s Reqorsa gene therapy secures another FDA fast...

Genprex has announced that the FDA has granted fast-track designation for Reqors...

Pfizer’s Ngenla finally secures FDA approval following ...

Pfizer has announced that the FDA has approved Ngenla (somatrogon-ghla), a paedi...

Cellusion shares pipeline update for eye disease stem c...

Cellusion shares Phase I/II clinical development plans for its bullous keratopat...

The promising role of GLP-1RAs in NASH

Research has shown that GLP-1RAs may have the potential to treat chronic metabol...

CRISPR gene editing on human embryos may have dangerous...

Experts warn caution around CRISPR gene editing technology on human embryos as i...

FDA rejects Alvotech’s Humira biosimilar for the third ...

While Alvotech aims to file a new application, the FDA's rejection delays the dr...

AstraZeneca’s STRIDE shows improved outcomes for liver ...

AstraZeneca has announced impressive results for its STRIDE regimen, significant...

Lantidra wins FDA approval as first-ever type 1 diabete...

The FDA has announced that Lantidra, a cellular therapy for type 1 diabetes, has...